Proton pump (H+/K+ -adenosine triphosphatase [ATPase]) inhibitors (PPIs) have been widely used for the treatment of acid-related disorders since the mid-1980s due to their strong anti-secretory effect, and have become one of the most important treatment strategies for acidrelated gastrointestinal disorders. 1 Both short-and longterm adverse effects of PPI use, including increased risk of infection, neoplasia and drug interaction, have been reported. PPIs may also affect gastric mucosal inflammation, attenuate neutrophil functions and cause hypochlorhydria. [2] [3] [4] Neutrophils have long been viewed as short-lived effector cells of the innate immune system; they are recruited to the site of inflammation and generate reactive oxygen and nitrogen species. 5 With their destructive potential, neutrophils enter peripheral tissue and interact closely with host cells. 5, 6 Helicobacter pylori (H. pylori) infection is a global threat and commonly persists for life unless treated. H. pylori is one of the major factors related to the pathogenesis of gastric mucosa injury and the main cause of chronic gastritis, gastric mucosal atrophy, peptic ulcer and some forms of gastric cancer. 7 The recruited neutrophils participate in the complex process of gastric inflammation, including biochemical tissue injury and immunological response. Although the precise mechanism of the development of gastritis is still not very clear, it may be related to the combined influences of bacterial toxin and cytokines on recruited neutrophils. 8 The first PPI, omeprazole, has been proven to attenuate neutrophil and lymphocyte functions in vitro. [9] [10] [11] [12] PPIs affect the interaction of neutrophils with endothelial cells and attenuate neutrophil association with chemostatic cytokines of gastric mucosa. 2, 4, 13 However, the effect of PPIs on gastric mucosa and neutrophils has not been thoroughly clarified. 14, 15 This study investigated the effect of PPIs on H. pylori, neutrophil infiltration and gastric antral mucosa inflammation.
Material and Methods

The patients
A total of 76 patients with gastritis, with or without peptic ulcer disease, were enrolled in the study. At least 2 biopsy specimens of antral mucosa of the stomach were taken during endoscopy for evaluation of the gastric mucosal inflammation status. Each patient's medical history and basic demographic data were obtained from their medical records and by taking their histories. All the subjects provided informed consent before the endoscopy. The study was approved by the Institutional Review Board of Taichung Veterans General Hospital.
Endoscopy and disease assessment
An experienced endoscopist performed the gastrointestinal endoscopies. Biopsy specimens were taken from the antrum of the stomach of all 76 patients to evaluate the gastric mucosal inflammatory status. Gastric ulcers, duodenal ulcers and reflux esophagitis were diagnosed endoscopically.
Histological assessments
Biopsy specimens were examined with hematoxylineosin (HE) staining. The specimens from the antrum were assessed for the presence of H. pylori, neutrophil infiltration, lymphocyte infiltration, glandular atrophy and intestinal metaplasia. Intestinal metaplasia was evaluated morphologically by the presence of goblet cells, absorptive cells and cells resembling clonocytes. Neutrophil infiltration was diagnosed by the presence of polymorphonuclear leukocytes in the lamina propria of the gastric mucosa. H. pylori infection, neutrophil infiltration, lymphocyte infiltration, intestinal metaplasia and glandular atrophy were classified as none, mild, moderate and severe according to the updated Sydney system. 16 
Statistical analysis
All the statistical analyses were carried out using the Statistical Package for Social Sciences (version 15.1; SPSS, Inc., Chicago, USA) and SAS 9.1.3 (SAS Institute Inc., Cary, USA). Continuous variables are expressed as means ± SD. The Kruskal-Wallis test or Mann-Whitney U test was used for inter-group comparisons of continuous variables. The χ 2 test with Yates' correction was used for the comparisons of discrete variables, gender, the presence/absence of H. pylori infection and the histology grading of neutrophil infiltration. Forward stepwise logistic regression analysis was used for comparisons of histological variables among PPI users and non-PPI users. For two-group comparisons a two-sided p value of less than 0.05 was considered statistically significant.
Results
PPI use, peptic ulcer type and H. pylori affect neutrophil infiltration
A total of 76 patients (46 females and 30 males, mean age 56.6 years) were examined. Among them 19 patients were taking PPIs and 57 patients were not taking PPIs in the 3 months prior to their endoscopic examinations. The baseline clinical characteristics of the patients and variables affecting neutrophil infiltration are shown in Table 1 . Among the 76 patients, there were no differences in grades of neutrophil infiltration based on age, gender, NSAID use and smoking history. The use of PPIs prior to endoscopic examination significantly affected neutrophil infiltration. The results demonstrated that patients who were taking PPIs tended to have less neutrophil infiltration in the gastric mucosa than non-PPI users.
PPI use modulates neutrophil infiltration, lymphocyte infiltration and atrophy of the mucosa
The histological characteristics of PPI users and non-PPI users are shown in Table 2 . Patients taking PPIs had less neutrophil infiltration and lymphocyte infiltration (p = 0.005 and 0.009, respectively). Though only 41 patients (54%) , the atrophy index of mucosa was also more severe in PPI users than non-PPI users. There were no significant differences in intestinal metaplasia between PPI and non-PPI users. Figure 1 shows the duration of PPI use among patients with different grades of gastric neutrophil infiltration (22 patients with no neutrophil infiltration, 26 with mild infiltration, 16 with moderate and 12 with marked infiltration; 79.32 ± 117.67, 26.12 ± 81.04, 8.38 ± 29.97, and 0.00 ± 0.00, respectively; p = 0.004). Patients with decreased neutrophil infiltration tended to have taken PPIs for longer durations prior to endoscopic examination. The duration of PPI use also had a significant effect on H. pylori infiltration (Fig. 2) .
The duration of PPI use correlated with inhibition of neutrophil and H. pylori infiltration
PPI use was associated with decreased neutrophil infiltration and increased mucosal atrophy
Tables 3 a and 3 b present the results of forward stepwise logistical regression analysis of PPI use. PPI use was associated with decreased neutrophil infiltration and increased mucosal atrophy. 
Discussion
The study showed that PPIs affect the microenvironment of the gastric mucosa. PPI users in the study group had less neutrophil and lymphocyte infiltration in the gastric mucosa than non-users. In addition, PPI use also affected H. pylori infiltration in the gastric mucosa and induced gland atrophy.
PPIs may affect leukocyte infiltration and the gastric mucosal gland. Furthermore, PPIs may be related to the course of gastric inflammation and carcinogenesis. A previous study suggested that PPIs may attenuate neutrophil-related oxidative stress and phagocytosis. 3, 9, 10, 12 PPI-induced agranulocytosis and impaired lymphocyte functions have recently been reported. 11, 17 The neutrophils that infiltrate gastric mucosa are affected by PPIs. PPIs can attenuate neutrophil adherence to endothelial cells by inhibiting the expression of adhesion molecules. 13 The results of the current study indicated that PPIs may attenuate the infiltration of neutrophils in the gastric antral mucosa. Infiltrating neutrophils play an important role in gastric mucosal injury, particularly in regard to oxidative stress and inflammatory cytokines. 6 Gastric mucosa neutrophils also defend against foreign bacterial infection. The effect of PPIs on gastric mucosa neutrophil-related oxidative stress and the innate immunity of neutrophils in the gastric mucosa need further investigation, particularly considering the heterogeneity of human hosts.
Gastric mucosa glandular distribution and inflammatory cytokine production are also affected by PPIs. Two components of gastric inflammatory status, intestinal metaplasia and glandular atrophy, have been studied. A previous report suggested PPI use may be related to mucosal atrophy, but not intestinal metaplasia. There also may be complex biological interactions among PPIs, H. pylori, gastritis and carcinogenesis, but the mechanisms of such interactions have not been clarified. In the natural course of H. pylori infection, the location of H. pylori, acid secretion, PPI use and neutrophil infiltration are all important components in the development of gastritis.
The effect of PPIs on gastric neoplasms has not yet been decisively clarified. PPI use may be related to atrophy of the gastric glands, which in turn may be linked to carcinogenesis. However, a relationship between PPI use and cancer has not been established. The results of animal studies on the role of PPIs in inflammation and carcinogenesis are controversial. Yeo et al. demonstrated that PPIs suppressed H. pylori-induced angiogenesis. 18 Hagiwara et al. reported that long-term PPI use exacerbated atrophic gastritis and promoted carcinogenesis. 19 In the present study, PPI use was related to glandular atrophy. PPIs may play a role in the course of gastritis, atrophic gastritis, intestinal metaplasia and carcinogenesis.
One limitation of this study was the small number of subjects enrolled; another was the fact that the quantity of neutrophils was not measured over the corpus of stomach. In addition, chemokine activity (for example, interleukin-8) was not evaluated in relation to neutrophil infiltration; clarification of the mechanism of neutrophil attraction will require further study.
Conclusions
The study showed that PPIs modified the microenvironment of gastric mucosa. PPIs use attenuated the infiltration of neutrophils and H. pylori in the gastric mucosa. The suppressive effect of PPIs on neutrophil and H. pylori infiltration was also related to the duration of PPI use.
